BioSpace News Archive

Policy

Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL

Antengene Corporation Limited announced that it has submitted a New Drug Application with Orphan Drug Designation to the South Korean Ministry of Food and Drug Safety for ATG-010 in combination with low dose dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma and for ATG-010 as monotherapy to treat adult patients with relapsed/refractory diffuse large B-cell lymphoma.

January 3, 2021
·
6 min read
Cosmetic Peptide Synthesis Market: Competitive Landscape & Geographical Outlook

Cosmetic peptide synthesis needs stricter quality control so as to ensure better reproducibility, improved peptide production along with large scale capacity for peptide synthesis.

January 3, 2021
·
5 min read
Melanoma Therapeutics Market: Increased Prevalence of Melanoma and Adoption of Therapeutics for Treatment to Boost Demand

The global melanoma therapeutics market is expected to be driven by the rising cases of melanoma and many other types of skin cancers.

January 3, 2021
·
4 min read
Homecare Oxygen Concentrators Market | Growing Incidence of Respiratory Disorders Drive Market

Homecare oxygen concentrators are usually used in providing supplemental oxygen to wide range of patients with respiratory problems.

January 3, 2021
·
3 min read
Filters Needles Market Detailed Study Analysis and Forecast by 2029

The expanding number of street mishaps across the globe is one of the main considerations driving the market.

January 3, 2021
·
3 min read
Anesthesia Disposables Market | Surge in the Prevalence of Chronic Diseases is likely to Bolster Demand for Anesthesia

Anesthesia refers to a form of medical treatment that induces temporary loss of sensation in patients for various medical purposes.

January 3, 2021
·
3 min read